Publications by authors named "Chelsea J Siwik"
Article Synopsis
- The study aimed to evaluate the effectiveness of a combined treatment for Major Depressive Disorder (MDD) that includes cognitive behavioral therapy (CBT) and whole-body hyperthermia (WBH).
- Sixteen adults participated in the trial, with most completing 4 WBH sessions and all completing the self-report depression assessments, showing significant improvements in depression symptoms.
- Although promising, the study's small sample size and design limit how widely the results can be applied, highlighting the need for larger future trials.
Article Synopsis
- The study investigates the relationship between body temperature and depression, hypothesizing that more severe depressive symptoms correlate with higher body temperature, smaller temperature differences between awake and asleep states, and lower temperature amplitude throughout the day.* -
- Using data from over 20,000 participants, the research found that both self-reported and wearable sensor data indicated higher body temperatures were linked to greater depression severity.* -
- While lower diurnal temperature amplitude also showed a trend towards being associated with higher depression severity, this result wasn’t statistically significant, suggesting that body temperature changes could be important in understanding and treating major depressive disorder.*
Purpose: National mandates require cancer centers provide comprehensive survivorship care. We created an 8-session, group intervention, the Survivorship Wellness Group Program (SWGP), that covered 8 topics: nutrition, physical activity, stress, sleep/fatigue, sexuality/body image, emotional wellbeing/fear of cancer recurrence, spirituality/meaning, and health promotion/goal setting. This study examined the acceptability and preliminary outcomes of SWGP.
View Article and Find Full Text PDFPurpose: To provide evidence-based recommendations to health care providers on integrative approaches to managing anxiety and depression symptoms in adults living with cancer.
Methods: The Society for Integrative Oncology and ASCO convened an expert panel of integrative oncology, medical oncology, radiation oncology, surgical oncology, palliative oncology, social sciences, mind-body medicine, nursing, methodology, and patient advocacy representatives. The literature search included systematic reviews, meta-analyses, and randomized controlled trials published from 1990 through 2023.
Background: Mindfulness-based cognitive therapy (MBCT) is an effective group intervention for reducing rates of depression relapse. However, about one-third of graduates experience relapse within 1 year of completing the course.
Objective: The current study aimed to explore the need and strategies for additional support following the MBCT course.
Objective: To examine the association between depressive symptoms, leukocyte telomere length-a marker of cellular ageing, and survival amongst lung cancer patients.
Design: Patients with non-small cell lung cancer were recruited from a university-affiliated cancer center clinic.
Main Outcome: Patients ( = 67) reported on depressive symptoms and provided a blood sample for leukocyte telomere length assessment at baseline and at a 3-month follow-up.
Article Synopsis
- Smoking is linked to lung cancer, leading to shame and guilt in patients, which can increase depression risk.
- A study using hierarchical regression showed that shame has a stronger connection to depressive symptoms than guilt.
- Higher self-compassion correlates with less shame and fewer depressive symptoms in lung cancer patients with a smoking history, suggesting that boosting self-compassion may help reduce shame and improve mental health.
Background: Head and neck cancers are associated with high rates of depression, which may increase the risk for poorer immediate and long-term outcomes. Here it was hypothesized that greater depressive symptoms would predict earlier mortality, and behavioral (treatment interruption) and biological (treatment response) mediators were examined.
Methods: Patients (n = 134) reported depressive symptomatology at treatment planning.